Published in J Clin Invest on March 01, 2005
Peptide antimicrobial agents. Clin Microbiol Rev (2006) 6.04
Host factors influencing susceptibility to HIV infection and AIDS progression. Retrovirology (2007) 1.77
Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection. J Virol (2005) 1.75
Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A (2006) 1.48
Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4(+) T cells. Immunol Cell Biol (2014) 1.46
Innate immunity against HIV: a priority target for HIV prevention research. Retrovirology (2010) 1.41
Innate immunity in the human female reproductive tract: endocrine regulation of endogenous antimicrobial protection against HIV and other sexually transmitted infections. Am J Reprod Immunol (2011) 1.40
Through the looking glass, mechanistic insights from enantiomeric human defensins. J Biol Chem (2009) 1.25
Antiviral mechanisms of human defensins. J Mol Biol (2013) 1.22
Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensin. J Biol Chem (2012) 1.18
Antimicrobial peptides in human skin disease. Eur J Dermatol (2007) 1.17
Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells. Retrovirology (2006) 1.17
Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission. J Immunol (2008) 1.15
Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells. J Biol Chem (2008) 1.12
Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples. Proteome Sci (2009) 1.10
Critical determinants of human α-defensin 5 activity against non-enveloped viruses. J Biol Chem (2012) 1.10
Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression. PLoS One (2010) 1.08
Microarray analysis of HIV resistant female sex workers reveal a gene expression signature pattern reminiscent of a lowered immune activation state. PLoS One (2012) 1.07
Antimicrobial peptides, skin infections, and atopic dermatitis. Semin Cutan Med Surg (2008) 1.06
Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms. PLoS One (2010) 1.03
Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women. J Acquir Immune Defic Syndr (2013) 0.94
HIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationships. PLoS One (2012) 0.94
High level expression of human epithelial beta-defensins (hBD-1, 2 and 3) in papillomavirus induced lesions. Virol J (2006) 0.93
HIV acquisition is associated with increased antimicrobial peptides and reduced HIV neutralizing IgA in the foreskin prepuce of uncircumcised men. PLoS Pathog (2014) 0.92
Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs (2013) 0.92
Antimicrobial Peptides in Human Sepsis. Front Immunol (2015) 0.88
Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cells. J Virol (2012) 0.88
Single, double and quadruple alanine substitutions at oligomeric interfaces identify hydrophobicity as the key determinant of human neutrophil alpha defensin HNP1 function. PLoS One (2013) 0.87
SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission. FEBS Lett (2007) 0.85
Antiviral activity of trappin-2 and elafin in vitro and in vivo against genital herpes. J Virol (2013) 0.85
Alpha-defensins 1-3 release by dendritic cells is reduced by estrogen. Reprod Biol Endocrinol (2011) 0.85
Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora. Antimicrob Agents Chemother (2006) 0.82
Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae. PLoS One (2012) 0.82
Anti-HIV activity of human defensin 5 in primary CD4+ T cells under serum-deprived conditions is a consequence of defensin-mediated cytotoxicity. PLoS One (2013) 0.82
17β-estradiol protects primary macrophages against HIV infection through induction of interferon-alpha. Viral Immunol (2014) 0.82
Genetic and Immunological Factors Involved in Natural Resistance to HIV-1 Infection. Open Virol J (2011) 0.81
Breast milk alpha-defensins are associated with HIV type 1 RNA and CC chemokines in breast milk but not vertical HIV type 1 transmission. AIDS Res Hum Retroviruses (2007) 0.81
Extracellular HIV-1 Tat induces human beta-defensin-2 production via NF-kappaB/AP-1 dependent pathways in human B cells. Mol Cells (2012) 0.81
Mechanisms of over-activated innate immune system regulation in autoimmune and neurodegenerative disorders. Neuropsychiatr Dis Treat (2007) 0.80
Sub-inhibitory concentrations of human α-defensin potentiate neutralizing antibodies against HIV-1 gp41 pre-hairpin intermediates in the presence of serum. PLoS Pathog (2013) 0.80
A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses. Peptides (2013) 0.79
Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites. J Virol (2012) 0.79
A compensatory mutation provides resistance to disparate HIV fusion inhibitor peptides and enhances membrane fusion. PLoS One (2013) 0.78
Human Alpha-Defensin HNP1 Increases HIV Traversal of the Epithelial Barrier: A Potential Role in STI-Mediated Enhancement of HIV Transmission. Viral Immunol (2015) 0.78
Therapeutic approaches using host defence peptides to tackle herpes virus infections. Viruses (2009) 0.78
UFFizi: a generic platform for ranking informative features. BMC Bioinformatics (2010) 0.78
Depot Medroxyprogesterone Acetate Use Is Associated With Elevated Innate Immune Effector Molecules in Cervicovaginal Secretions of HIV-1-Uninfected Women. J Acquir Immune Defic Syndr (2015) 0.77
Genetic Markers of the Host in Persons Living with HTLV-1, HIV and HCV Infections. Viruses (2016) 0.76
The Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal Mucosa. Antibiotics (Basel) (2014) 0.75
IFN-ε protects primary macrophages against HIV infection. JCI Insight (2016) 0.75
Amniotic fluid exhibits an innate inhibitory activity against HIV type 1 replication in vitro. AIDS Res Hum Retroviruses (2012) 0.75
A screen for genetic suppressor elements of hepatitis C virus identifies a supercharged protein inhibitor of viral replication. PLoS One (2013) 0.75
Vitamin D and Infectious Diseases: Simple Bystander or Contributing Factor? Nutrients (2017) 0.75
Innate immune recognition. Annu Rev Immunol (2001) 26.65
An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (1987) 19.23
HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell (1990) 17.60
Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science (1995) 17.42
Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol (2003) 11.11
Change in coreceptor use correlates with disease progression in HIV-1--infected individuals. J Exp Med (1997) 11.01
Innate immunity. N Engl J Med (2000) 7.03
Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Science (2000) 7.01
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci U S A (1992) 6.85
Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol (1993) 5.36
Antibacterial peptides: basic facts and emerging concepts. J Intern Med (2003) 4.44
Epithelial antibiotics induced at sites of inflammation. Science (1995) 3.61
Mammalian defensins in immunity: more than just microbicidal. Trends Immunol (2002) 3.52
Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol (2002) 3.46
Defensins of vertebrate animals. Curr Opin Immunol (2002) 3.41
Direct inactivation of viruses by human granulocyte defensins. J Virol (1986) 3.00
Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr Biol (1995) 2.83
Retracted Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science (2002) 2.81
Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS (2003) 2.55
The entry of entry inhibitors: a fusion of science and medicine. Proc Natl Acad Sci U S A (2003) 2.43
CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest (1991) 2.40
Cytotoxic T lymphocytes against HIV. AIDS (1990) 2.24
Retrocyclin: a primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1. Proc Natl Acad Sci U S A (2002) 2.14
Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function. J Infect Dis (2003) 1.97
Retrocyclin, an antiretroviral theta-defensin, is a lectin. J Immunol (2003) 1.69
ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB. J Biol Chem (1999) 1.58
Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis. J Lab Clin Med (1993) 1.57
Non-cytolytic CD8 T-cell anti-HIV responses in primary HIV-1 infection. Lancet (1994) 1.40
The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses (2003) 1.40
Innate immune activation as a broad-spectrum biodefense strategy: prospects and research challenges. J Allergy Clin Immunol (2003) 1.34
alpha-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors. AIDS (2003) 1.34
Mechanism of mammalian cell lysis mediated by peptide defensins. Evidence for an initial alteration of the plasma membrane. J Clin Invest (1991) 1.33
Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul Pept (2001) 1.30
Trans-activation of HIV-1 LTR-directed gene expression by tat requires protein kinase C. EMBO J (1990) 1.29
Protection from HIV/AIDS: the importance of innate immunity. Clin Immunol (2003) 1.24
Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature (1988) 1.20
Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc Natl Acad Sci U S A (1993) 1.19
CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol (2003) 1.17
Human alpha-defensin regulates smooth muscle cell contraction: a role for low-density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Blood (2002) 1.16
Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J Leukoc Biol (1997) 1.14
Defensins inhibit HIV replication in vitro. AIDS (1993) 1.11
Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin. Proc Natl Acad Sci U S A (1989) 1.04
Activating protein-1 cooperates with phorbol ester activation signals to increase HIV-1 expression. AIDS (1996) 1.03
Inhibition of protein kinase C by defensins, antibiotic peptides from human neutrophils. Biochem Pharmacol (1988) 1.02
Association between elevated neutrophil defensin levels and endometritis. J Infect Dis (2002) 1.01
Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA. Virology (2002) 0.99
The cAMP-dependent protein kinase A and protein kinase C-beta pathways synergistically interact to activate HIV-1 transcription in latently infected cells of monocyte/macrophage lineage. Virology (1998) 0.99
Establishment of radioimmunoassay for human neutrophil peptides and their increases in plasma and neutrophil in infection. Biochem Biophys Res Commun (1993) 0.95
Inactivation of the human immunodeficiency virus by hypericin: evidence for photochemical alterations of p24 and a block in uncoating. AIDS Res Hum Retroviruses (1992) 0.95
Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism. Antimicrob Agents Chemother (1998) 0.93
Innate and adaptive mucosal immunity in protection against HIV infection. Vaccine (2003) 0.91
Human immunodeficiency virus type 1 Tat-mediated trans activation correlates with the phosphorylation state of a cellular TAR RNA stem-binding factor. J Virol (1992) 0.90
Amniotic fluid defensins: potential markers of subclinical intrauterine infection. Clin Infect Dis (1998) 0.90
Retraction of an interpretation. Science (2004) 0.87
Role of protein kinase C-beta isozyme in activation of latent human immunodeficiency virus type 1 in promonocytic U1 cells by phorbol-12-myristate acetate. AIDS Res Hum Retroviruses (1996) 0.86
Innate immunity and HIV. AIDS (2001) 0.84
Human immunodeficiency virus type 1 (HIV-1) infection and expression in intestinal epithelial cells: role of protein kinase A and C pathways in HIV-1 transcription. J Infect Dis (1999) 0.84
Levels of antimicrobial molecules defensin and lactoferrin are elevated in the cerebrospinal fluid of children with meningitis. Pediatrics (1999) 0.78
Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease. Nat Genet (2003) 2.88
Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality. AIDS (2006) 2.28
Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med (2002) 2.10
Chronic kidney disease in HIV infection: an urban epidemic. AIDS (2007) 1.97
Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol (2005) 1.94
HIV-1 Nef induces proliferation and anchorage-independent growth in podocytes. J Am Soc Nephrol (2002) 1.79
Nef stimulates proliferation of glomerular podocytes through activation of Src-dependent Stat3 and MAPK1,2 pathways. J Clin Invest (2004) 1.71
Candidate topical microbicides bind herpes simplex virus glycoprotein B and prevent viral entry and cell-to-cell spread. Antimicrob Agents Chemother (2004) 1.69
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy. J Am Soc Nephrol (2011) 1.67
Virological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cells. J Am Soc Nephrol (2011) 1.66
Human immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular disease. Am J Pathol (2008) 1.60
PRO 2000 gel inhibits HIV and herpes simplex virus infection following vaginal application: a double-blind placebo-controlled trial. J Infect Dis (2005) 1.54
HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J Acquir Immune Defic Syndr (2006) 1.37
HIV-1 Nef induces dedifferentiation of podocytes in vivo: a characteristic feature of HIVAN. AIDS (2005) 1.36
The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int (2008) 1.33
Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action. Antimicrob Agents Chemother (2005) 1.31
Successful immunization with a single injection of non-integrating lentiviral vector. Mol Ther (2007) 1.31
Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection. J Infect Dis (2005) 1.29
Phosphatidylinositol 3-kinase regulates human immunodeficiency virus type 1 replication following viral entry in primary CD4+ T lymphocytes and macrophages. J Virol (2003) 1.26
Career outcomes of the graduates of the American Board of Internal Medicine Research Pathway, 1995-2007. Acad Med (2013) 1.24
CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol (2003) 1.17
Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease. J Am Soc Nephrol (2006) 1.17
HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages. Viral Immunol (2005) 1.15
alpha-Defensin inhibits influenza virus replication by cell-mediated mechanism(s). J Infect Dis (2007) 1.14
Persulfated molecular umbrellas as anti-HIV and anti-HSV agents. J Am Chem Soc (2004) 1.07
HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells. Kidney Int (2008) 1.05
A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J Virol (2002) 1.03
ACIDFORM inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations. J Infect Dis (2006) 1.02
Neisseria gonorrhoeae enhances HIV-1 infection of primary resting CD4+ T cells through TLR2 activation. J Immunol (2010) 1.01
FAT10: a novel mediator of Vpr-induced apoptosis in human immunodeficiency virus-associated nephropathy. J Virol (2009) 1.00
Defensins: natural anti-HIV peptides. AIDS Rev (2004) 0.99
Nef expressed from human immunodeficiency virus type 1 extrachromosomal DNA downregulates CD4 on primary CD4+ T lymphocytes: implications for integrase inhibitors. J Gen Virol (2005) 0.97
Retroviral E-DNA: persistence and gene expression in nondividing immune cells. J Leukoc Biol (2006) 0.95
Prothymosin-alpha inhibits HIV-1 via Toll-like receptor 4-mediated type I interferon induction. Proc Natl Acad Sci U S A (2010) 0.95
Podocan, a novel small leucine-rich repeat protein expressed in the sclerotic glomerular lesion of experimental HIV-associated nephropathy. J Biol Chem (2003) 0.92
HIV-1 viral protein r induces ERK and caspase-8-dependent apoptosis in renal tubular epithelial cells. AIDS (2010) 0.92
Development and use of SIV-based Integrase defective lentiviral vector for immunization. Vaccine (2009) 0.92
Lentiviral gene transduction of kidney. Hum Gene Ther (2002) 0.92
HIV-1 Vpr activates the DNA damage response in renal tubule epithelial cells. AIDS (2009) 0.90
Gonococcal lipooligosaccharide suppresses HIV infection in human primary macrophages through induction of innate immunity. J Infect Dis (2006) 0.89
Kidney and central nervous system as reservoirs of HIV infection. Curr Opin HIV AIDS (2006) 0.89
Nonintegrating Lentiviral Vector-Based Vaccine Efficiently Induces Functional and Persistent CD8+ T Cell Responses in Mice. J Biomed Biotechnol (2010) 0.87
Topical microbicides: the time has come. AIDS Read (2006) 0.86
The homophilic adhesion molecule sidekick-1 contributes to augmented podocyte aggregation in HIV-associated nephropathy. FASEB J (2007) 0.86
SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission. FEBS Lett (2007) 0.85
Transduction of human antigen-presenting cells with integrase-defective lentiviral vector enables functional expansion of primed antigen-specific CD8(+) T cells. Hum Gene Ther (2010) 0.85
In vivo gene transfer to kidney by lentiviral vector. Kidney Int (2002) 0.85
Mucosal human defensins 5 and 6 antagonize the anti-HIV activity of candidate polyanion microbicides. J Innate Immun (2010) 0.84
Rigorous pre-clinical evaluation of topical microbicides to prevent transmission of human immunodeficiency virus. J Antimicrob Chemother (2003) 0.84
The differential binding and activity of PRO 2000 against diverse HIV-1 envelopes. J Acquir Immune Defic Syndr (2009) 0.84
Dual tropism of HIV-1 envelopes derived from renal tubular epithelial cells of patients with HIV-associated nephropathy. AIDS (2006) 0.83
The imperative to invest in science has never been greater. J Clin Invest (2014) 0.82
Absence of erythrocyte-associated HIV-1 in vivo. J Infect Dis (2007) 0.81
Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines. Retrovirology (2012) 0.81
Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell-mediated human immunodeficiency virus transfer. Antimicrob Agents Chemother (2008) 0.81
Patterns of variation among distinct alleles of the Flag silk gene from Nephila clavipes. Int J Biol Macromol (2006) 0.80
Postintegration HIV-1 infection of cervical epithelial cells mediates contact-dependent productive infection of T cells. J Infect Dis (2013) 0.80
Renal epithelial cells produce and spread HIV-1 via T-cell contact. AIDS (2014) 0.80
Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma. Circulation (2013) 0.80
Identification of HIV-1 genitourinary tract compartmentalization by analyzing the env gene sequences in urine. AIDS (2015) 0.77
Polarity of alpha-galactosidase A uptake by renal tubule cells. Kidney Int (2002) 0.77
A fine line between molecular umbrella transport and ionophoric activity. Bioconjug Chem (2009) 0.75
HIV infection-induced transcriptional program in renal tubular epithelial cells activates a CXCR2-driven CD4+ T-cell chemotactic response. AIDS (2016) 0.75
Murine granulocyte-macrophage colony-stimulating factor expressed from a bicistronic simian immunodeficiency virus-based integrase-defective lentiviral vector does not enhance T-cell responses in mice. Viral Immunol (2014) 0.75
HIV-1 dynamics in haemodialysis patients. AIDS (2002) 0.75
Zoonotic infections: an emerging threat to human health. Mt Sinai J Med (2009) 0.75